We found no correlation between BUB1B expression levels and somatic KRAS mutation status (Figure S7A); however, BUB1B expression levels were significantly higher in lung adenocarcinomas harboring somatic TP53 mutations (Figure S7B). This evidence concerns the gene KRAS and lung adenocarcinoma.